BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23677874)

  • 1. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
    Friedmann AM; Wolfson JA; Hudson MM; Weinstein HJ; Link MP; Billett A; Larsen EC; Yock T; Donaldson SS; Marcus K; Krasin MJ; Howard SC; Metzger ML
    Pediatr Blood Cancer; 2013 Sep; 60(9):1458-63. PubMed ID: 23677874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
    Voss SD; Chen L; Constine LS; Chauvenet A; Fitzgerald TJ; Kaste SC; Slovis T; Schwartz CL
    J Clin Oncol; 2012 Jul; 30(21):2635-40. PubMed ID: 22689804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma.
    Huynh-Le MP; Walker AJ; Kominers SD; Paz-Priel I; Wharam MD; Terezakis SA
    Pediatr Blood Cancer; 2014 Jul; 61(7):1210-4. PubMed ID: 24523203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
    El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
    Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
    Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
    Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
    Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
    Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
    Gorde-Grosjean S; Oberlin O; Leblanc T; Pacquement H; Donadieu J; Lambilliotte A; Schell M; Dommange F; Munzer M; Paillard C; Schmitt C; Lutz P; Edan C; Ansoborlo S; Stephan JL; Michel G; Thomas C; Perel Y; Robert A; Landman-Parker J
    Br J Haematol; 2012 Sep; 158(5):649-56. PubMed ID: 22757721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience.
    Roerden M; Sökler M; Kanz L; Bethge W; Vogel W; Walz JS
    Ann Hematol; 2020 Feb; 99(2):265-276. PubMed ID: 31897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches to the management of pediatric Hodgkin lymphoma.
    Freed J; Kelly KM
    Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Hodgkin lymphoma: are we over-scanning our patients?
    Rathore N; Eissa HM; Margolin JF; Liu H; Wu MF; Horton T; Kamdar K; Dreyer Z; Steuber P; Rabin KR; Redell M; Allen CE; McClain KL; Guillerman RP; Bollard CM
    Pediatr Hematol Oncol; 2012 Aug; 29(5):415-23. PubMed ID: 22632168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.
    Ozuah NW; Dahmoush HM; Grant FD; Lehmann LE; LaCasce AS; Billett AL; Margossian SP
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28696028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation.
    Taçyıldız N; Tanyıldız HG; Ünal E; Dinçaslan H; Asarcıklı F; Aksoy BA; Vatansever G; Yavuz G
    Turk J Pediatr; 2019; 61(5):671-676. PubMed ID: 32104998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
    El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
    Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
    Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
    J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.
    Chera BS; Olivier K; Morris CG; Lynch JW; Mendenhall NP
    Am J Clin Oncol; 2007 Dec; 30(6):601-6. PubMed ID: 18091054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
    Uematsu M; Tarbell NJ; Silver B; Coleman CN; Rosenthal DS; Shulman LN; Canellos G; Weinstein H; Mauch P
    Cancer; 1993 Jul; 72(1):207-12. PubMed ID: 7685241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
    Ram R; Gooley TA; Maloney DG; Press OW; Pagel JM; Petersdorf SH; Shustov AR; Flowers ME; O'Donnell P; Sandmaier BM; Storb RF; Gopal AK
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1537-45. PubMed ID: 21536145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.